ライフサイエンスコーパス: misdiagnosis

1 isdiagnosed, with child abuse being a common misdiagnosis.

2 icient examination and imaging can result in misdiagnosis.

3 ween BTV and EHDV often results in serologic misdiagnosis.

4 uggestive of SAH may reduce the frequency of misdiagnosis.

5 location were independently associated with misdiagnosis.

6 ly small tissue samples, raising the risk of misdiagnosis.

7 emonium, further adding to the potential for misdiagnosis.

8 equired given their rarity and potential for misdiagnosis.

9 ght have been reduced due to common clinical misdiagnosis.

10 experienced difficulties with IBD diagnosis/misdiagnosis.

11 d control to exclude CHIP variants and avoid misdiagnosis.

12 se often resemble each other and can lead to misdiagnosis.

13 curate and complex, leading to high rates of misdiagnosis.

14 ther the patient experienced harm due to the misdiagnosis.

15 1 and type 2 diabetes has frequently led to misdiagnosis.

16 gesting under-reporting, under-diagnosis, or misdiagnosis.

17 d-dependent, and underestimation may lead to misdiagnosis.

18 However, this diagnosis is susceptible to misdiagnosis.

19 . restricta with C. albicans may lead to its misdiagnosis.

20 s different skin types, leading to potential misdiagnosis.

21 l tests may lead the health care provider to misdiagnosis.

22 ke to gain insight into sources of ED stroke misdiagnosis.

23 iomarker reliability, potentially leading to misdiagnosis.

24 the diagnostic scope and addresses potential misdiagnosis.

25 was associated with the occurrence of prior misdiagnosis.

26 cognitively unimpaired, suggesting possible misdiagnosis.

27 otor and non-motor symptoms with a degree of misdiagnosis.

28 f the population-based AChE baseline-induced misdiagnosis.

29 ion of MRI diagnostic criteria contribute to misdiagnosis.

30 ic specialists, as well as a reduced risk of misdiagnosis.

31 referral experienced harm as a result of the misdiagnosis.

32 Overreliance on OCT can result in misdiagnosis.

33 and adult-onset NPC and are associated with misdiagnosis.

34 ity can undermine patient care by leading to misdiagnosis.

35 eness among health care providers leading to misdiagnosis.

36 ssful therapy to the same extent as outright misdiagnosis.

37 rasound, where scarce data leads to frequent misdiagnosis.

38 itivity to PCP without further testing risks misdiagnosis.

39 pretation of the results frequently leads to misdiagnosis.

40 These challenges can lead to misdiagnosis.

41 al, as misclassification can lead to genetic misdiagnosis.

42 cancer by identifying cases at high risk of misdiagnosis.

43 short time interval (eg, 2 weeks) to reduce misdiagnosis.

44 can show atypical presentation and result in misdiagnosis.

45 essed during inflammation, which may lead to misdiagnosis.

46 review of the clinical data suggested CDSRR misdiagnosis.

47 ; reliance on one test alone courts frequent misdiagnosis.

48 he following strategies could help to reduce misdiagnosis.

49 A previous misdiagnosis (124 patients [4.0%]) was more frequently a

50 ders not understanding the technology (71%), misdiagnosis (62%), and cost (59%) were the most common.

51 s of tick-borne infections can often lead to misdiagnosis affecting treatment and the prevalence data

52 direct evidence is needed about why and how misdiagnosis affects the poor and vulnerable.

53 for a scientific commentary on this article.Misdiagnosis among tremor syndromes is common, and can i

54 No association was found between misdiagnosis and 30-day mortality (adjusted odds ratio [

55 at has likely contributed to higher rates of misdiagnosis and adverse side effects from drug treatmen

56 Misdiagnosis and delayed diagnosis are common where the

57 iagnostic capacity frequently contributes to misdiagnosis and delays in outbreak detection and respon

58 gic confirmation of EoE, which can result in misdiagnosis and diagnostic delays.

59 ppropriate methodology is paramount to avoid misdiagnosis and guide therapy.

60 of metabolites in circulation may result in misdiagnosis and improper treatments.

61 s in disease, but children remain at risk of misdiagnosis and inadequate treatment.

62 ociated with psychotic disorders, leading to misdiagnosis and inappropriate treatment with antipsycho

63 d inappropriate diagnostic tests may lead to misdiagnosis and inappropriate treatment.

64 liance on a signle negative test may lead to misdiagnosis and inappropriate treatment.

65 s may be harmful because they may facilitate misdiagnosis and inappropriate triage.

66 Misdiagnosis and incorrect treatment choices are likely

67 tive versus past infection which can lead to misdiagnosis and incorrect understanding of the epidemio

68 Mr Ezekiel's son endured years of misdiagnosis and ineffective treatments until the correc

69 Recognition of these findings can prevent misdiagnosis and may prove helpful in the planning of ap

70 riate data filtering, can lead clinicians to misdiagnosis and medical error.

71 quent histological display can help to avoid misdiagnosis and mismanagement.

72 verestimation of BP readings and may lead to misdiagnosis and overestimation of hypertension.

73 For AASs, both misdiagnosis and overtesting are key concerns, and stand

74 levated office BP screening results to avoid misdiagnosis and overtreatment of persons with isolated

75 ad to empiric treatment, potentially causing misdiagnosis and overtreatment of STIs.

76 ns other than PCa, it leads to high rates of misdiagnosis and overtreatment.

77 the field to adapt to new concepts to avoid misdiagnosis and overtreatment.

78 ese techniques, thereby reducing the risk of misdiagnosis and patient apprehension regarding inconclu

79 ted methods of testing to reduce rates of PG misdiagnosis and patient misclassification in clinical t

80 ng VEGF testing into screening could prevent misdiagnosis and reduce costs.

81 al raised reading in the clinic would reduce misdiagnosis and save costs.

82 non-AL amyloidosis, highlighting the risk of misdiagnosis and the need for unequivocal amyloid typing

83 eated presumptively as malaria, resulting in misdiagnosis and the overuse of antimalarial drugs.

84 for the clinical diagnosis of COPD to avoid misdiagnosis and to ensure proper evaluation of severity

85 icians has created concerns about diagnosis, misdiagnosis and treatment.

86 false-positive mRDTs may also contribute to misdiagnosis and unnecessary antimalarial use in clinica

87 detailed case-level review to avoid genetic misdiagnosis and unnecessary referrals.

88 bility of early treatment, and to help avoid misdiagnosis and unnecessary therapy.

89 ia, but also the measures we use to minimize misdiagnosis and unnecessary treatment of patients witho

90 These findings highlight the potential for misdiagnosis and unnecessary treatment when commensal Ne

91 e rheumatic manifestations in order to avoid misdiagnosis and unnecessary treatment with potentially

92 t is immune mediated, sometimes resulting in misdiagnosis and unnecessary treatment.

93 ide effects, 33% on lack of efficacy, 21% on misdiagnosis, and 10% on cost/insurance.

94 ree of concern related to burden of disease, misdiagnosis, and common MG treatments among those with

95 ardiovascular-metabolic disease, microscopic misdiagnosis, and delay in commencing intravenous treatm

96 ns for image interpretation and avoidance of misdiagnosis, and extend the recommendations to the use

97 rnative diagnoses, potential contributors to misdiagnosis, and immunotherapy adverse reactions.

98 ic minority population, delayed diagnosis or misdiagnosis, and presenting during the COVID-19 pandemi

99 haracterisation, reduce diagnostic delay and misdiagnosis, and provide insights into the pathophysiol

100 on, identification of clinical red flags for misdiagnosis, and use of biomarkers enable early diagnos

101 Underdiagnosis and misdiagnosis are common, response assessment remains cha

102 Delayed diagnosis and misdiagnosis are frequent in people with amyotrophic lat

103 otics after a TFNE, in many cases because of misdiagnosis, are risk factors for ICH, and therefore ac

104 Misdiagnosis as age-related macular degeneration should

105 Previous misdiagnosis as inflammatory disease was common.

106 The risk of misdiagnosis as more aggressive lymphomas, causing patie

107 A-mutant GISTs, increasing the likelihood of misdiagnosis as other types of sarcoma.

108 al, and laboratory findings commonly lead to misdiagnosis as pneumonia and substantially delay an acc

109 Misdiagnosis as primary cerebral vasculitis and aneurysm

110 electron microscopy are essential to prevent misdiagnosis as primary FSGS since kidney survival depen

111 Initial misdiagnosis as retinitis (n = 5), hemangioma (n = 1), c

112 ance of normal thyroid gland can prevent its misdiagnosis as tumor.

113 tions, however, are inefficient and prone to misdiagnosis, as they rely on qualitative observations o

114 Delays in treatment related to misdiagnosis, as well as resistance to current antiviral

115 wever, completely exclude the possibility of misdiagnosis bias, if prodromal symptoms of AMI were mis

116 psoriasis by patients, as well as potential misdiagnosis by clinicians.

117 se gains, incomplete clinical evaluation and misdiagnosis by referring clinicians is common and assoc

118 Underdiagnosis or misdiagnosis can increase the risk of severe complicatio

119 Autoimmune encephalitis misdiagnosis can lead to harm.

120 ist and treatments for the 2 species differ, misdiagnosis can lead to poor outcomes in either disease

121 Misdiagnosis can lead to unnecessary dietary and social

122 multiple sclerosis from these disorders, but misdiagnosis can occur.

123 r QCM could identify both false negative and misdiagnosis cases of routine microscopy.

124 ritical, but 3 common misconceptions lead to misdiagnosis: Clostridium difficile infection is a possi

125 wards patients with FND, including harm from misdiagnosis, delayed diagnosis and treatment, direct ha

126 Such misdiagnosis delays antibiotic therapy, which likely pla

127 Misdiagnosis due to analysis errors is rare.

128 ood biomarkers in clinical practice to avoid misdiagnosis due to false positives.

129 agnostic enigma for clinicians with frequent misdiagnosis due to lack of rapid and accurate diagnosti

130 ed with risk for longer diagnostic delay and misdiagnosis emerged, and these should be addressed in f

131 Misdiagnosis error rates decreased with increased monito

132 Possible misdiagnosis, especially in women, should be explored.

133 ms and benefits of psychiatric diagnosis and misdiagnosis existed, as well as better access to effect

134 Misdiagnosis extended beyond a year in 5 of 25 DA cases

135 disease are nonspecific and often result in misdiagnosis, failure of treatment, and poor clinical ou

136 To avoid a delayed diagnosis or a misdiagnosis, familiarity with typical and atypical imag

137 e possibility of different rates of clinical misdiagnosis for carriers vs. noncarriers.

138 Encephalitis is a common misdiagnosis for PS and migraine with visual aura for IC

139 The misdiagnosis had a direct effect on patient care, though

140 nt had major accuracy limitations, including misdiagnosis; however, direct harms of measurement were

141 a cutoff of 0.3 ISU/l, leading to a risk of misdiagnosis if only one of both tests is used.

142 he National Health Service and could prevent misdiagnosis in 16 cases per annum.

143 he National Health Service and could prevent misdiagnosis in 16 cases per annum.

144 month-25 years), with a high rate of initial misdiagnosis in 52%.

145 accurately quantify axonal injury leading to misdiagnosis in a proportion of patients.

146 Misdiagnosis in functional limb weakness is rare after l

147 The likelihood of misdiagnosis in people with OSA based on a single night

148 Misdiagnosis in POEMS syndrome results in diagnostic del

149 etically complex disorder, which can lead to misdiagnosis in the early stages.

150 dictors of resection, rate and predictors of misdiagnosis in the surgical cohort and time trends of m

151 y clinical practice and a potential cause of misdiagnosis in this patient cohort.

152 Misdiagnosis included 4 mCRCs treated with ICI, of which

153 Potential contributors to misdiagnosis included overinterpretation of positive ser

154 ctive age, the population-based incidence of misdiagnosis increased 1% per year (P =.005).

155 The incidence of misdiagnosis increased 8% yearly in patients older than

156 als who initially present in good condition, misdiagnosis is associated with increased mortality and

157 ce, diagnosis is typically delayed by years, misdiagnosis is common, and delivery of effective therap

158 Although delayed and initial misdiagnosis is common, most patients show improved symp

159 ung and middle-aged individuals, but initial misdiagnosis is common.

160 e pelvic radiographs (PXRs) are widely used, misdiagnosis is common.

161 Misdiagnosis is hazardous to the patient.

162 findings permit recognition of this disease, misdiagnosis is not uncommon.

163 is has created a situation where the rate of misdiagnosis is unacceptably high (up to 43%).

164 To reduce this risk of misdiagnosis, it is important that clinicians understand

165 Contrary to expectation, the frequency of misdiagnosis leading to unnecessary appendectomy has not

166 We estimate cellulitis misdiagnosis leads to 50000 to 130000 unnecessary hospit

167 Autoimmune encephalitis misdiagnosis leads to morbidity from unnecessary immunot

168 ng that reduced overdiagnosis and/or reduced misdiagnosis may be an explanatory factor.

169 lammatory demyelinating polyneuropathy; this misdiagnosis may lead to delayed therapy and progressive

170 Misdiagnosis may lead to different surgical procedures s

171 Misdiagnosis may lead to incorrect treatment or unwarran

172 Differential diagnosis is important, because misdiagnosis may lead to unnecessary procedures and prol

173 ic or even iatrogenic rupture, as in case of misdiagnosis, may cause anaphylactic reactions and disse

174 ressed in the existing psychiatric research: misdiagnosis, medication nonadherence, and treatment eff

175 ng of health-care professionals resulting in misdiagnosis, mismanagement, and wastage of resources.

176 ecruited, controlled cohort design to assess misdiagnosis, mortality and symptomatic and health outco

177 Misdiagnosis occurred mostly in case of macrocystic/unil

178 ferential diagnosis should be considered and misdiagnosis occurs in many settings including at specia

179 common neurodegenerative disorder for which misdiagnosis occurs in up to 30% of patients after initi

180 diagnosis of PFS ensures the avoidance of a misdiagnosis of a primary peanut or tree nut allergy or

181 nd CT findings resulted in underdiagnosis or misdiagnosis of acute biliary disease in eight of 11 pat

182 Misdiagnosis of acute myocardial infarction (AMI) may si

183 ate and rapid in-office test can prevent the misdiagnosis of adenoviral conjunctivitis that leads to

184 ttle evidence of widespread overdiagnosis or misdiagnosis of ADHD or of widespread overprescription o

185 Misdiagnosis of AIP can result in major surgery for a st

186 This is largely due to the initial misdiagnosis of AK as herpetic keratitis.

187 Misdiagnosis of AL can lead to inappropriate use of chem

188 are conditions, HCS can significantly reduce misdiagnosis of anaemia compared with clinical assessmen

189 ation of bone lesions and thus helping avoid misdiagnosis of bone metastasis; however, CT revealed mo

190 quires unique diagnostic criteria to avoid a misdiagnosis of cutaneous mastocytosis per current World

191 Misdiagnosis of DCHR is common and the macroscopic appea

192 Patient care may be impacted by the misdiagnosis of DENV and CHIKV in areas where both virus

193 resentation may lead to delayed diagnosis or misdiagnosis of disease, wide application of approved in

194 Misdiagnosis of eyelid amyloidosis is usual when the les

195 decrease in HD incidence can be explained by misdiagnosis of HD as NHL.

196 dynamic measurements, potentially leading to misdiagnosis of HFpEF.

197 ment of CSF pressure, delays in diagnosis or misdiagnosis of idiopathic intracranial hypertension and

198 Misdiagnosis of infection is among the most commonly mad

199 einemic keratopathy which lead to an initial misdiagnosis of infectious crystalline keratopathy.

200 Conversely, the misdiagnosis of inherited bone marrow failure (BMF) can

201 Misdiagnosis of lower extremity cellulitis is common and

202 Conclusions and Relevance: Misdiagnosis of lower extremity cellulitis is common and

203 umerous concerns regarding the potential for misdiagnosis of Lyme disease using commercial assays hav

204 Indirect evidence strongly suggests that misdiagnosis of malaria contributes to a vicious cycle o

205 malignant melanocytes was the main cause for misdiagnosis of malignant conjunctival tumors with IVCM.

206 nes with limited evidence of causality risks misdiagnosis of maturity-onset diabetes of the young (MO

207 ls from malignant melanocytes to prevent the misdiagnosis of melanoma using IVCM.

208 Misdiagnosis of meningitis as malaria was common.

209 Failure to test ocular motility may lead to misdiagnosis of Moebius syndrome, especially in patients

210 Misdiagnosis of mucositis and angioedema may delay appro

211 internal standards as controls, may lead to misdiagnosis of neoplasms as cysts.

212 Misdiagnosis of neuro-ophthalmic conditions, mismanageme

213 on of cultural or spiritual context to avoid misdiagnosis of neuropsychiatric disease.

214 The misdiagnosis of nonepileptic seizure is costly to patien

215 arly pregnancy failure potentially result in misdiagnosis of nonviability or poor prognosis when appl

216 n (IOI) is inconsistent, leading to frequent misdiagnosis of other orbital entities, including cancer

217 ile most 'SWEDD' cases are due to a clinical misdiagnosis of PD, there exists a small proportion of p

218 en false information, fueling arguments over misdiagnosis of persistent vegetative state and raising

219 asthma, which could in part be explained by misdiagnosis of persisting pulmonary toxicity.

220 Misdiagnosis of presumed appendicitis is an adverse outc

221 search regarding the sources contributing to misdiagnosis of psychiatric disorders in this population

222 renosum is a diagnosis of exclusion, and the misdiagnosis of pyoderma gangrenosum can result in subst

223 The misdiagnosis of pyoderma gangrenosum is not uncommon and

224 In this study, misdiagnosis of SAH occurred in 12% of patients and was

225 Limitations of this study include potential misdiagnosis of T2D and lack of detailed data of drug us

226 Misdiagnosis of the deformities is common-particularly w

227 amiliarity with T. foetus in cats as well as misdiagnosis of the organisms as Pentatrichomonas homini

228 y pinpointing the causes of resurgence, with misdiagnosis of the problem epidemiologically ineffectiv

229 t findings with both modalities will lead to misdiagnosis of the spinal level by two or more segments

230 Misdiagnosis of the syndrome, as well as misunderstandin

231 Misdiagnosis of this phenomenon can often occur due to o

232 s of MECs was demonstrated in order to avoid misdiagnosis of this rare type of tumor.

233 mployed to evaluate treatment responses, but misdiagnosis of TTP or PsP may lead to continuation of i

234 e cultures are nonspecific and often lead to misdiagnosis of urinary tract infection and unnecessary

235 f motor output and may therefore lead to the misdiagnosis of vegetative state or minimally conscious

236 In Africa, underreporting and misdiagnosis often mask its true epidemiology, and dengu

237 ssive temporal dispersion and a high rate of misdiagnosis, often as acquired demyelinating neuropathy

238 Mozambique, to assess the impact of clinical misdiagnosis on mortality rates and to evaluate the accu

239 To avoid misdiagnosis, only genes with strong evidence of causali

240 ic strategies to reduce delayed diagnosis or misdiagnosis, optimize management, and improve understan

241 y presents in an atypical fashion leading to misdiagnosis or a delay in diagnosis.

242 Misdiagnosis or comorbidity with affective, anxiety and

243 n such confusing, complicated cases, because misdiagnosis or delay in the right diagnosis can result

244 Presentations span multiple specialties and misdiagnosis or delayed diagnosis is commonplace.

245 evidence of Mycobacterium tuberculosis, and misdiagnosis or delayed diagnosis often occurs as a cons

246 adolescents is unique, causing high rates of misdiagnosis or delayed treatment.

247 es are at risk of iatrogenic harm because of misdiagnosis or inaccurate prediction of future decline.

248 ely initiation of revascularization, missed, misdiagnosis or late diagnosis have unfavorable medical

249 The main cause of LQTS misdiagnosis or overdiagnosis was a prolonged QTc interv

250 Misdiagnosis or underdiagnosis of rare diseases in patie

251 de of endemic area) and false negatives (eg, misdiagnosis or underreporting).

252 Misdiagnosis, or delayed diagnosis, of MMP with ocular i

253 Although common, VWD is at risk of misdiagnosis, overdiagnosis and underdiagnosis owing to

254 The misdiagnosis perpetuated the unnecessary removal of tree

255 notype Latent variable Extraction of disease misdiagnosis (PheLEx), a GWAS analysis framework that le

256 Misdiagnosis predisposes to antibiotic overuse and propa

257 rget population to optimize use and minimize misdiagnosis, prior to widespread deployment, particular

258 dominated by themes of impact on life (29%), misdiagnosis problems (27%), treatment issues (24%), and

259 ria have the potential to reduce the risk of misdiagnosis, provide information on optic neuritis dise

260 avioural assessment and help reduce the high misdiagnosis rate reported in these patients.

261 comes included appropriateness of referrals, misdiagnosis rate, interventions undergone before referr

262 e diagnosis is difficult, with a rather high misdiagnosis rate.

263 l epileptiform discharges (IEDs) and overall misdiagnosis rates of epilepsy are 20% to 30%.

264 ith use of the tiny, small, and medium ROIs, misdiagnosis rates would be 2.3%, 0.5%, and 0.5%, respec

265 ied BP screening approaches seem to have low misdiagnosis rates, and cardiovascular risk could be low

266 Tuberculosis (TB) misdiagnosis remains a public health concern, especially

267 Multiple sclerosis (MS) misdiagnosis remains an important issue in clinical prac

268 mong neurologists has increased, the rate of misdiagnosis remains high, resulting in significant diag

269 However, radiologic performance may lead to misdiagnosis, rendering questionable the use of chest co

270 ontribution of non-target exosomes, reducing misdiagnosis risk.

271 were excluded from the final analysis due to misdiagnosis (standard of care n=4, standard of care plu

272 rge series, pediatric HSK had a high rate of misdiagnosis, stromal involvement, recurrence, and visio

273 r toxin B alone will result in more frequent misdiagnosis than testing for both toxins.

274 of cerebellar infarction, from diagnosis and misdiagnosis to patients' monitoring, treatment, and pot

275 rovider (unadjusted OR 3.9; 95% CI 1.7-8.8), misdiagnosis (unadjusted OR 6.8; 95% CI 2.5-18.7), being

276 attern of SH3TC2-related neuropathy to avoid misdiagnosis, unnecessary ancillary tests and treatment.

277 with normal mental status at first contact, misdiagnosis was associated with worse QOL at 3 months a

278 Misdiagnosis was defined as failure to correctly diagnos

279 Misdiagnosis was determined in a consensus meeting using

280 Misdiagnosis was found in one patient in the functional

281 A high rate of initial misdiagnosis was noted, with six patients initially diag

282 Misdiagnosis was restricted to clonal complex 5, a hospi

283 ribution of a gene to ARVC can contribute to misdiagnosis, we assembled an international multidiscipl

284 To minimize the issue of potential misdiagnosis, we have also performed the analysis includ

285 nostic delay (ie, 1.5 x 75th percentile) and misdiagnosis were assessed.

286 ction, and optimal TST cutpoints to minimize misdiagnosis, were computed for different assumptions ab

287 hy and to determine which most often lead to misdiagnosis when evaluated by a glaucoma specialist.

288 missed, or confused with mimics, leading to misdiagnosis, which significantly affects patients' qual

289 d prevent such harms, such as ways to reduce misdiagnosis with a focus on rule in signs, optimizing t

290 Whereas misdiagnosis with MSISensor even increased when analyzin

291 no mutations were identified, 3 were due to misdiagnosis, with the remaining 2 likely carrying LMAN1